These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 36593066)

  • 1. Molecular underpinnings of exceptional response in primary malignant melanoma of the esophagus to anti-PD-1 monotherapy.
    Dai J; Bai X; Gao X; Tang L; Chen Y; Sun L; Wei X; Li C; Qi Z; Kong Y; Cui C; Chi Z; Sheng X; Xu Z; Lian B; Li S; Yan X; Tang B; Zhou L; Wang X; Xia X; Guo J; Mao L; Si L
    J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36593066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Epigenetic Profiling Reveals Distinct Features of Mucosal Melanomas Associated with Immune Cell Infiltration and Their Clinical Implications.
    Dai J; Jia J; Zhang F; Liu K; Xi Y; Yuan P; Mao L; Bai X; Wei X; Wang B; Li J; Xu Y; Liu T; Chang S; Shao Y; Guo J; Ying J; Si L
    Cancer Res Commun; 2024 May; 4(5):1351-1362. PubMed ID: 38695555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive genomic analysis of primary malignant melanoma of the esophagus reveals similar genetic patterns compared with epithelium-associated melanomas.
    Li J; Liu B; Ye Q; Xiao X; Yan S; Guan W; He L; Wang C; Yu Z; Tai Z; Pei S; Ma Y; Li S; Wang Y; Wu N
    Mod Pathol; 2022 Nov; 35(11):1596-1608. PubMed ID: 35688970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive clinicopathological and molecular analysis of primary malignant melanoma of the oesophagus.
    Tsuyama S; Kohsaka S; Hayashi T; Suehara Y; Hashimoto T; Kajiyama Y; Tsurumaru M; Ueno T; Mano H; Yao T; Saito T
    Histopathology; 2021 Jan; 78(2):240-251. PubMed ID: 32654197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic mutations in primary malignant melanoma of the esophagus: case report and literature review.
    Sanlorenzo M; Ribero S; Osella Abate S; Mariani S; Strignano P; Salizzoni M; Savoia P; Fierro MT; Quaglino P
    G Ital Dermatol Venereol; 2020 Oct; 155(5):680-682. PubMed ID: 33295742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiregional Sequencing Reveals Genomic Alterations and Clonal Dynamics in Primary Malignant Melanoma of the Esophagus.
    Li J; Yan S; Liu Z; Zhou Y; Pan Y; Yuan W; Liu M; Tan Q; Tian G; Dong B; Cai H; Wu N; Ke Y
    Cancer Res; 2018 Jan; 78(2):338-347. PubMed ID: 28972077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal genomic alternations and clonal dynamics analysis of primary malignant melanoma of the esophagus.
    Li J; Guan W; Ren W; Liu Z; Wu H; Chen Y; Liu S; Quan X; Yang Z; Jiang C; He J; Xiao X; Ye Q
    Neoplasia; 2022 Aug; 30():100811. PubMed ID: 35661532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive molecular findings in primary malignant melanoma of the esophagus: A multicenter study.
    Deng L; Wang HY; Hu CF; Liu XY; Jiang K; Yong JJ; Wu XY; Guo KH; Wang F
    Pigment Cell Melanoma Res; 2024 May; 37(3):363-371. PubMed ID: 38158377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical pathological features of 180 cases with primary esophageal malignant melanoma].
    Meng H; Zhao XK; Song X; Han WL; Zhou SL; Sun L; Hu SJ; Cheng R; Wang M; Yin YH; Li YZ; Ding Y; Wang LD
    Zhonghua Zhong Liu Za Zhi; 2021 Sep; 43(9):949-954. PubMed ID: 34530578
    [No Abstract]   [Full Text] [Related]  

  • 10. Primary malignant melanoma of the esophagus: A retrospective analysis of clinical features, management, and survival of 76 patients.
    Wang X; Kong Y; Chi Z; Sheng X; Cui C; Mao L; Lian B; Tang B; Yan X; Si L; Guo J
    Thorac Cancer; 2019 Apr; 10(4):950-956. PubMed ID: 30864295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and prognosis of primary malignant melanoma of the esophagus.
    Chen H; Fu Q; Sun K
    Medicine (Baltimore); 2020 Jul; 99(28):e20957. PubMed ID: 32664098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological Features, Staging Classification, and Clinical Outcomes of Esophageal Melanoma: Evaluation of a Pooled Case Series.
    Sun H; Zhu N; Gong L; Lan L; Yu Z; Pan Z
    Front Oncol; 2022; 12():858145. PubMed ID: 35847861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary malignant melanoma of the esophagus: a case report.
    Li YH; Li X; Zou XP
    World J Gastroenterol; 2014 Mar; 20(10):2731-4. PubMed ID: 24627611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary esophageal malignant melanoma successfully treated with anti-PD-1 antibody for retroperitoneal recurrence after esophagectomy: A case report.
    Endo F; Akiyama Y; Onishi M; Fujisawa R; Sasaki N; Nikai H; Baba S; Sugimoto R; Kimura T; Takahara T; Iwaya T; Otsuka K; Nitta H; Koeda K; Sugai T; Sasaki A
    Int J Surg Case Rep; 2020; 75():152-156. PubMed ID: 32950945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome of esophagectomy for primary malignant melanoma of the esophagus: a single-institute retrospective analysis.
    Harada K; Mine S; Yamada K; Shigaki H; Oya S; Baba H; Watanabe M
    Dis Esophagus; 2016 May; 29(4):314-9. PubMed ID: 25708974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and surgical outcomes for primary malignant melanoma of the esophagus: a single-center experience.
    Wang S; Tachimori Y; Hokamura N; Igaki H; Kishino T; Kushima R
    Ann Thorac Surg; 2013 Sep; 96(3):1002-6. PubMed ID: 23810175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological characteristics, staging classification, and survival outcomes of primary malignant melanoma of the esophagus.
    Sun H; Gong L; Zhao G; Zhan H; Meng B; Yu Z; Pan Z
    J Surg Oncol; 2018 Mar; 117(4):588-596. PubMed ID: 29266237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologic subtypes of melanoma predict survival benefit of combination anti-PD1+anti-CTLA4 immune checkpoint inhibitors versus anti-PD1 monotherapy.
    Rose AAN; Armstrong SM; Hogg D; Butler MO; Saibil SD; Arteaga DP; Pimentel Muniz T; Kelly D; Ghazarian D; King I; Kamil ZS; Ross K; Spreafico A
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33483342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
    Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
    Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status of primary malignant melanoma of the esophagus: clinical features, pathology, management and prognosis.
    Iwanuma Y; Tomita N; Amano T; Isayama F; Tsurumaru M; Hayashi T; Kajiyama Y
    J Gastroenterol; 2012 Jan; 47(1):21-8. PubMed ID: 22048255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.